• On June 15, 2026, Amcor plc reported that longtime Division President of Global Flexible Packaging Solutions, Fred Stephan, had retired from his officer role effective June 30, 2026, with incoming division president Ryan D. Yost stepping in from Avery Dennison to lead the business.
• By pairing Stephan’s advisory role through year-end 2026 with Yost’s background in transforming complex materials businesses, Amcor is aiming to balance leadership continuity with fresh operational focus in one of its core packaging segments.
• We’ll now examine how Yost’s experience reshaping materials and identification businesses could influence Amcor’s existing investment narrative and execution priorities.

Invest in the nuclear renaissance through our list of 89 elite nuclear energy infrastructure plays powering the global AI revolution.

Amcor Investment Narrative Recap

To own Amcor, you need to believe that scale in flexible and rigid packaging, the Berry integration, and portfolio pruning can lift margins despite soft volumes and leverage. The Yost appointment looks incremental rather than transformational for the near term, with the key short term catalyst still the pace of Berry synergies, and the biggest risk remaining weak demand and execution around divesting underperforming assets.

Among recent announcements, the change in fiscal year end to a December close stands out in relation to this leadership shift. It will shape how investors track early Berry synergy delivery and any operational impact from new management, but it does not, by itself, change the core questions around portfolio review, divestiture timing, or the load from higher capital spending and debt.

Yet alongside this leadership change, investors should be aware that...

Amcor’s narrative projects $23.9 billion revenue and $1.6 billion earnings by 2029.

Uncover how Amcor's forecasts yield a $48.21 fair value, a 12% upside to its current price.

Exploring Other Perspectives

Some of the most optimistic analysts were assuming revenue could reach about US$25.8 billion and earnings US$2.3 billion by 2028, which is a much rosier view than the consensus and may look different once Yost’s impact on Berry integration and cost execution becomes clearer.

Explore 6 other fair value estimates on Amcor - why the stock might be worth as much as 75% more than the current price!

Form Your Own Verdict

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Amcor research is our analysis highlighting 2 key rewards and 4 important warning signs that could impact your investment decision.
• Our free Amcor research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Amcor's overall financial health at a glance.

Ready For A Different Approach?

The market won't wait. These fast-moving stocks are hot now. Grab the list before they run:

• AI is about to change healthcare. These 39 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• Uncover the next big thing with 22 elite penny stocks that balance risk and reward.
• Find 43 companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.